IR Basic Policy
Basic Policy on Disclosure
The MEDIPAL Group conducts measures emphasizing the maximizing of enterprise value while ensuring management transparency and soundness. Based on the principles of transparency, fairness, continuity, we provide shareholders, investors, customers, and all stakeholders with information disclosure in accordance with rules on timely disclosure prescribed by the Financial Instruments and Exchange Act and the Tokyo Stock Exchange (hereafter, “rules on timely disclosure”). We also disclose, in a proactive and equitable manner, information not subject to laws, regulations, or rules on timely disclosure, but that we consider useful for stakeholders.
Means of Disclosure
Company information subject to rules on timely disclosure is released through the Tokyo Stock Exchangeʼs Timely Disclosure Network (TDnet), and afterward promptly posted on the Companyʼs website. Information not subject to disclosure laws and regulations is disclosed using the most suitable method, such as posting on the Companyʼs website.
Matters Regarding Results Forecasts and Future Projections
The results forecasts and future projections included in the information disclosed by MEDIPAL HOLDINGS are predictions determined by the Company based on information limited to that available at the time of disclosure, and include latent risks and uncertainties. Accordingly, actual results and other outcomes may vary due to a variety of reasons. Material factors that may affect actual results include the economic conditions surrounding the MEDIPAL HOLDINGS Group, reforms to the health care system, changes in the market environment, and competition.